Management of Benign Prostatic Hypertrophy - part 7 pps
Management of Benign Prostatic Hypertrophy - part 7 pps
... D, et al. High-intensity focused ultrasound in
the treatment of benign prostatic hyperplasia. Br J Urol 19 97; 79: 177 .
22. Sanghvi NT, Foster RS, Bihrle R, et al. Noninvasive surgery of prostate ... Long-term
outcome of transrectal high-intensity focused ultrasound therapy for benign
prostatic hyperplasia. Eur Urol 2000; 37: 6 87.
27. Uchida T, Muramoto M, Kyunou H, et al. C...
Management of Benign Prostatic Hypertrophy - part 3 pps
... include α1A-, α1B-, and α1D-
receptors (13). The α1A-receptors constitute approx 70 % of the prostatic
α1-receptors (14). Subtypes of α1A-receptors include α1A1-receptors
(wild type), α1A2-receptors, ... EVALUATION AND SELECTION OF THERAPY
SELECTION OF AN α-ANTAGONIST AGENT
α-ANTAGONISTS IN NON-BPH PATIENTS
CONCLUSIONS
REFERENCES
INTRODUCTION
The development of benign prostati...
Management of Benign Prostatic Hypertrophy - part 4 ppsx
... biochemical effi-
cacy after single and multiple oral administration of N-(2-methyl-2-propyl )-3 -
oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide, a new type of specific
competitive inhibitor of testosterone ... Urol
19 97; 1 57: 134.
38. Marks LS, Partin AW, Gormley GJ, et al. Prostate tissue composition and
response to finasteride men with symptomatic benign prostatic hyper...
Management of Benign Prostatic Hypertrophy - part 1 pptx
... the United States of America. 10 9 8 7 6 5 4 3 2 1
E-ISBN: 1-5 925 9-6 4 4-4
Library of Congress Cataloging-in-Publication Data
Management of benign prostatic hypertrophy / edited by Kevin T. McVary.
... address or at any of the following numbers: Tel.: 97 3-2 5 6-1 699;
Fax: 97 3-2 5 6-8 341, E-mail: humana@humanapr.com; or visit our Website: http://humana...
Management of Benign Prostatic Hypertrophy - part 2 pdf
... in benign prostatic
hypertrophy. Urology 1 979 ;14:634–6 37.
69. Pradhan BK, Chandra K. Morphogenesis of nodular hyperlasia—prostate. J
Urol 1 975 ;113(2):210–213.
70 . Moore RA. Benign hypertrophy of ... The use of alpha-adrenergic blockers in benign
prostatic obstruction. Br J Urol 1 976 ;48:255–263.
60. Lepor H. Adrenergic blockers for the treatment of benign pros...
Management of Benign Prostatic Hypertrophy - part 5 ppt
... 9.3 10 .7
15 24 17. 7 7. 7 9.3 11.6
Schulman and Zlotta 36 12 21.6 7. 8 9.9 16.8
17 36 21.6 7. 6 9.9 16.2
Virdi et al. 71 36 22.3 7. 4 7. 0 16.1
IPSS
Qmax (mL/sec)
Chapter 9 / TUIP 125
125
From: Management ... al. 72 12 20.8 6.2 8.2 15.9
42 18 20.8 6 .7 8.2 14.9
Steele and Sleep 41 12 22.4 7. 0 6.6 10.2
38 24 22.4 9.5 6.6 11.0
Schatzl et al. 15 6 17. 7 8 .7 9.3 13.6
15 12 17. 7...
Management of Benign Prostatic Hypertrophy - part 6 ppt
... prostatec-
tomy best performed? BJU Int. 1999;84 (7) :79 5 79 8.
42. Kabalin JN, Gilling PJ, Fraundorfer MR. Holmium:yttrium-aluminum-garnet
laser prostatectomy. Mayo Clin Proc. 1998 ;73 (8) :79 2 79 7.
43. ... Urol
1992 ;70 : 174 – 177 .
67. Holtgrew HL. American Urological Association survey of transurethral pros-
tatectomy and the impact of changing medicare reimbursement. Urol Clin N...
Management of Benign Prostatic Hypertrophy - part 8 pptx
... Urol 19 97; 7:25–36.
Chapter 13 / Treatment of BPH 211
211
From: Management of Benign Prostatic Hypertrophy
Edited by: K. T. McVary © Humana Press Inc., Totowa, NJ
13
Treatment of Benign Prostatic
Hyperplasia ... the PFR increased from a baseline
of 7. 4 ± 2.6 mL/s to 17. 3 ± 2 .7 mL/s (p < 0.02) at 3 mo (4). PVR improved
from a baseline of 57. 56 ± 17. 7 mL to 43 ....
Management of Benign Prostatic Hypertrophy - part 10 pdf
... side effects, 67, 74
history of use for benign
prostatic hyperplasia, 62
lower urinary tract symptom
management in non -benign
prostatic hyperplasia
patients, 72 , 73
mechanism of action, 62, 63
patient ... transurethral resec-
tion and superpubic prostatectomy and benign prostatic hypertrophy. Eur Urol
1991;20: 272 .
25. Ertekin C, Yurtseven O, Reel F. Bulbocavernosus...
Từ khóa: